Functionally, rhPAI-1 administration reduced sweat secretion and serum acetylcholine levels in a pilocarpine-induced hyperhidrosis mouse model, supporting the therapeutic potential of targeting the PAI-1/CHRNA1 pathway in PFH. This evidence concerns the gene SERPINE1 and Hyperhidrosis.